NeuroSense Therapeutics Ltd

Finance

Wall Street analysts’ outlook for NeuroSense Therapeutics Ltd (NRSN)

Cody Benson

With 0.1 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.32 million ...

Business

The time has not yet come to remove your chips from the table: NeuroSense Therapeutics Ltd (NRSN)

Colin Adrian

With 0.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.32 million ...

Tech

Taking on analysts’ expectations and winning: NeuroSense Therapeutics Ltd (NRSN)

Rosalind Gate

With 0.15 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.31 million ...

Tech

Get in on NeuroSense Therapeutics Ltd’s (NRSN) buy-in window today!

Rosalind Gate

With 0.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.61 million ...

Sete News
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.